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Differential miRNAs expression 
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Radiotherapy is a fundamental step in the treatment of breast cancer patients. The treatment efficiency 
is however reduced by the possible onset of radiation resistance. In order to develop the effective 
treatment approach, it is important to understand molecular basis of radiosensitivity in breast cancer. 
The purpose of the present study was to investigate different radiation response of breast cancer 
cell lines, and find out if this response may be related to change in the microRNAs expression profile. 
MDA-MB-231 and T47D cells were subjected to different doses of radiation, then MTT and clonogenic 
assays were performed to assess radiation sensitivity. Cytofluorometric and western blot analysis were 
performed to gain insight into cell cycle distribution and protein expression. MicroRNA sequencing 
and bioinformatics prediction methods were used to identify the difference in microRNAs expression 
between two breast cancer cells and the related genes and pathways. T47D cells were more sensitive to 
radiation respect to MDA-MB-231 cells as demonstrated by a remarkable G2 cell cycle arrest followed 
by a greater reduction in cell viability and colony forming ability. Accordingly, T47D cells showed higher 
increase in the phosphorylation of ATM, TP53 and CDK1 (markers of radiation response) and faster and 
more pronounced increase in RAD51 and γH2AX expression (markers of DNA damage), when compared 
to MDA-MB-231 cells. The two cell lines had different microRNAs expression profiles with a confirmed 
significant differential expression of miR-16-5p, which targets cell cycle related genes and predicts 
longer overall survival of breast cancer patients, as determined by bioinformatics analysis. These results 
suggest a possible role for miR-16-5p as radiation sensitizing microRNA and as prognostic/predictive 
biomarker in breast cancer.
Breast cancer (BC) is one of leading cause of mortality among women worldwide1. Radiotherapy (RT) is currently 
used as the standard treatment for control of breast cancer2. Although up to 83% of early- stage diagnosed breast 
cancer cases can be treated by postoperative radiotherapy, some patients will suffer from spread metastasis and 
recurrence after radiation therapy3. The failure in RT application might be due to radiation resistance, which 
caused by remaining the cells have greater tolerance to ionizing radiation (IR) or the intrinsic resistance4.
Ionizing radiation can cause direct DNA strand break or producing free radicals, leading to more damages 
in DNA or other cell components. DNA lesions activate the DNA damage response (DDR), which essential for 
activation of downstream signaling pathways such as DNA repair, cell cycle arrest or apoptosis5. Breast cancer 
cells respond to radiation in different ways, depending on their different biological and molecular characteris-
tic6,7. Understanding the molecular mechanism behind the differential response to radiation is important toward 
a possible personalized use of radiotherapy in patients with different BC subtype. Furthermore, identification of 
specific molecular target can be used to better classify BC patients8.
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Variation in radiation sensitivity could be influenced by gene expression and post translational modification9. 
MicroRNAs (miRNAs) are the group of short noncoding RNA that mostly have negative regulatory effect on gene 
expression10. They can regulate almost all cellular processes including DNA repair, cell cycle arrest, apoptosis, 
and survival11. Not surprisingly, miRNAs have been identified as modulator of radiation responses12. The rela-
tion between deregulated expression of miRNAs and radiation response has been also observed in breast cancer 
cells13,14. For instance, miR-668 could mediate radiation resistance by targeting the NF-κB pathway15 or miR-21 is 
well-known miRNA involved in radioresistance by regulation of G2/M checkpoint12; on the other side, miR-200c 
could enhance radiation sensitivity through inhibiting expression of DNA repair genes and autophagy16,17 and 
miR-620 was upregulated in irradiated breast cancer cells, and its silencing contributed to reduce cell survival 
following exposure18.
Although many clinical studies have identified the specific miRNAs which associated with radiation sensitiv-
ity19–21, cell-based studies are needed to better understand the role of specific miRNAs in the response to radiation 
and possibly verify if they can be used as new biomarkers of radioresistance. In the present study, we aimed to 
investigate if radiotherapy could commonly alter the expression of selected miRNAs in two breast cancer cell 
lines, namely MDA-MB-231 and T47D, that have different radiosensitivity.
Results
Radiation reduced cell viability and colony forming ability of T47D cells. To evaluate radiation 
sensitivity, three breast cancer cell lines were exposed to increasing dose of radiation and analyzed for cell viability 
using the MTT assay at different time points after irradiation. As it shown in Fig. 1a, using MDA-MB-231 cells, 
significant reduction in cells viability was observed only at the doses of 6 and 10 Gy after 72 hours. Conversely, in 
both SKBR3 and T47D, cell viability gradually decreased with increasing dose of radiation becoming significant 
Figure 1. T47D cells are the most sensitive to radiation-induced cell death. (a–c) MTT assay evaluating cell 
viability of MDA-MB-231 (a), SKBR3 (b) and T47D (c) exposed to different radiation doses (2, 6, and 10 Gy) 
and evaluated 24, 48, or 72 hours after the irradiaition. The LD50 reported in the Fig (a-c). was caculated 
for each cell line four days after irradiation. Data represent the mean ± standard deviation (SD) of three 
experiments, each performed in triplcate. Statistical significance was evaluated using two-way analysis of 
variance (ANOVA), with Tukey’s multiple comparison test. (d) Survival curve of MDA-MB-231 and T47D cell 
evaluated by their colony forming ability using the indicated radiation doses. Data represent the mean ± SD of 
two independent experiments, each performed in triplicate. Multiple t-test, using the Holm-Sidak method, was 
used to statistical comparison. *p < 0.05, **p < 0.01, ***p < 0.001 and ns (not significant).
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after 48 hours of incubation, when compared to non-irradiated control cells (Fig. 1b,c). These differences were 
more evident in T47D cells as demonstrated by the calculation of their LD50 (i.e. the dose of radiation which kills 
the 50 percent of cells) four days after irradiation. Indeed, the estimated LD50 values were of 9.26, 5.20, and 3.94 
for MDA-MB-231, SKBR3 and T47D, respectively. Based on these results, we selected the MDA-MB-231 and 
T47D, as the two cell lines with the highest difference in the response to radiation.
The above data were confirmed by the evaluation of colony forming ability of MDA-MB-231 and T47D irra-
diated cells showing that the survival fraction of cells exposed to 2 Gy radiation dose was 72.4% and 53.1% for 
MDA-MB-231 and T47D cells, respectively and that statistically significant differences in cell survival were pres-
ent in the range of 4 to 10 Gy (Fig. 1d). Cell survival curve was fitted to Linear Quadratic (LQ) model, and α and 
β parameters were calculated for each cell line. The α represents cell death at low dose, resulting from single radi-
ation event. The β term describes the cell killing at high dose, caused by interaction of damage from two separate 
radiation events. The higher α and β indicate more radiation sensitivity. The higher α value confirmed the higher 
radiosentivity of T47D cells, whereas no difference was seen between β values (Table 1).
Induction of G2/M arrest by ionizing radiation in T47D cells. We next evaluated the cell cycle dis-
tribution of irradiated cells collected 24 and 48 hours after irradiation. As shown in Fig. 2a,b, radiation clearly 
changed cell cycle distribution in both cell lines, with differences more prominent in T47D compared to 
MDA-MB-231 cells as evaluated by a dose response curve using of cells collected 24 hours after radiation. In 
particular, at this time point, T47D cells showed dose-dependent accumulation of the cells in G2/M and subG1 
(apoptotic/dead cells) phases of the cell cycle (Fig. 2b). Conversely, at the 24 hours timepoint, MDA-MB-231 cells 
started to accumulate in the G2/M phase of the cell cycle only at doses ≥6 Gy and failed to accumulate in subG1, 
again demonstrating a higher resistance to radiation respect to T47D. Next, the analysis of cell cycle distribution 
over the time demonstrated that independently on the dose used, MDA-MB-231 cells completely recovered from 
IR within 48 hours with a minimal accumulation of the subG1 population (likely necrotic/apoptotic cells), while 
T47D cells at the 48 hours timepoint maintained the G2/M block and progressively accumulated in the subG1 
phase of the cell cycle (Fig. 2c,d).
Different expression pattern of cell cycle and DNA repair related proteins in T47D cells. The 
differences in cell cycle distribution were accompanied by biochemical differences in key signal transduction 
pathways, as evaluated by western blot looking at the expression of selected phosphorylated proteins. To use a 
clinical relevant conditions and to better highlight the differences between RT-sensitive and –resistant cells, we 
used the 2 Gy (dose used in fractionated RT) and the 0.5 Gy doses. Irradiated cells were harvested at different 
time points (i.e. 1, 8 and 24 hours after radiation) and cell lysates analyzed by western blot. In MDA-MB-231 cells 
the expression of both pSer1981-ATM and pTyr1068- EGFR, two known mechanisms of resistance to radiation, 
rapidly increased (onehour timepoint) (Fig. 3a, left panels). The increased expression of pSer1981-ATM remained 
higher than the one observed in non-irradiated cells up to 24 hours after irradiation, while EGFR phosphoryla-
tion even increased over the same period of time (Fig. 3a, left panels). In T47D, ATM phosphorylation increased 
8 hours after irradiation both at 0.5 and 2 Gy doses while EGFR phosphorylation was only slightly modified by 
irradiation at all the considered time points (Fig. 3a Right panels).
The expression of pSer15-TP53 and pTyr15-CDK1, used as markers of cell cycle arrest and apoptosis and 
G2/M transition respectively, was evaluated on the same lysate. Results show that in MDA-MB-231 cells, irradia-
tion induced a biphasic increase of pSer15-TP53 at one and 24 hours timepoints. These changes were independent 
on the dose used (Fig. 3a, left panels). The expression of pTyr15-CDK1 (a phosphorylation event that prevents 
the fully activation of CDK1 and thus, when present, it blocks the cell cycle at the G2/M transition), was only 
slightly modified by 0.5 Gy dose and started to increase with the 2 Gy dose at 24 hours after treatment (Fig. 3a, left 
panels). In T47D cells, both the increase in pSer15-TP53 and pTyr15-CDK1 was dose dependent. However, while 
pSer15-TP53 expression increased after one hour of treatment and remained high over the whole period of obser-
vation, with only a small decrease 24 hours after irradiation, pTyr15-CDK1 increased at the 8 hours timepoint and 
remained high up to 24 hours after treatment (Fig. 3a, right panels), in line with the G2/M accumulation observed 
in FACS analyses (Fig. 2).
Finally, we evaluated the expression of two markers of DNA damage, namely RAD51 and γH2AX (i.e. Ser139 
phosphorylated Histone H2X). In T47D, RAD51 expression increased rapidly and remained high up to 24 hours 
while γH2AX expression reached a peak 4 hours after irradiation and then rapidly decreased (Fig. 3b, left panels). 
In MDA-MB-231 cells, the levels of RAD51 increased only at 24 hours post irradiation while γH2AX expression 
was only slightly modified over the considered period of time (Fig. 3b, right panels).
MicroRNA expression profiling identified upregulation of miR-23b-3p, miR-16-5p in radiosensi-
tive breast cancer cells. Data collected so far indicated that T47D and MDA-MB-231 had different sensitiv-
ity to irradiation with differences in cell cycle distribution and signaling pathways activation. We thus investigated 
if these differences were also accompanied by differences in miRNAs expression using microRNAs sequencing. 
The miRNAs expression level in MDA-MB-231 and T47D irradiated cells collected 24 hours after the treatment 
α (Gy−1) β(Gy−1) SF2
MDA-MB-231 0.069 ± 0.018 0.049 ± 0.016 0.72 ± 0.069
T47D 0.22 ± 0.0051 0.048 ± 0.0053 0.48 ± 0.089
Table 1. Radiobiological parameters of cell survival curve. The α and β describe cell radiosensitivity, cells with 
higher α or β are more sensitive to radiation. SF2: Survival fraction at dose 2 Gy.
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was compared with their non-expression in not-exposed control. In MDA-MB-231, we found 88 differentially 
expressed miRNAs of which 44 were upregulated and 44 were downregulated in irradiated cells. A larger propor-
tion of miRNAs was modified in T47D cells where we found 183 were upregulated and 59 were downregulated 
by 2 Gy irradiation (Table 2). The most upregulated and downregulated miRNAs in radiation treated T47D and 
MDA-MB-231 cells are reported in Fig. 4a,b. When we look closer to the expression of the miRNAs mostly 
modified in the two cell lines, we observed that the miR-23b-3p and miR-16-5p were commonly modified by 
irradiation being upregulated in T47D and downregulated in MDA-MB-231 (Fig. 4c).
Figure 2. T47D cells display a prolonged G2/M arrest after irradiation. (a,b) Graphs reporting the cell cycle 
distribution of MDA-MB-231 (a) and T47D (b) treated with 2–10 Gy of radiation and analyzed 24 hours after 
irradiation. Data represent the mean of two independent experiments. (c) Isograms reporting the cell cycle 
distribution of MDA-MB-231 (c) and T47D (d) irradiated with 2, 6 and 10 Gy, and analyzed 24 and 48 hours 
after irradiation. A typical experiment is shown.
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The miR-16-5p showed different expression in radioresistant compared to radiosensitive 
cells. To validate the miRNA-Seq results and evaluation of the difference in miR-16-5p expression after irra-
diation, we used quantitative real-time polymerase chain reaction (qRT-PCR) on RNA extracted from both cell 
lines 24 hours after irradiation with 2 Gy. In line with the miRNA sequencing results, we found a two-fold increase 
in miR-16-5p expression in irradiated T47D respect to non-irradiated cells, while no significant differences were 
observed between irradiated and non-irradiated MDA-MB-231 cells (Fig. 5).
The miR-16-5p targets prediction and pathway enrichment analysis. The potential target genes of 
miR-16-5p were retrieved by online TargetScan database, after setting threshold ranging from −1 to −0.4 for total 
score and then visual mapped in Cytoscape (Fig. 6a). The repression of the target gens are defined by the com-
plementary features between miRNA and mRNAs, as negative score represent better repression22. To explore the 
probable biological function and related pathway, Gene Ontology and KEGG enrichment analysis were predicted 
through Enrichr online database. The results showed the correlation between target genes and negative regula-
tion of mitotic cell cycle (GO: 0045930), G2 DNA damage checkpoint (GO: 0031572), regulation of response to 
DNA damage stimulus (GO: 2001020), activation of MAPKKK activity (GO: 0000185), cellular response to UV 
(GO: 0034644), DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest 
(GO: 0006977), cytoplasmic sequestering of NF-kappaB (GO: 0007253) and DNA damage induced protein phos-
phorylation (GO: 0006975). KEGGG pathway analysis also indicated that cell cycle is the downstream pathway 
principally related to miR-16-5p (Fig. 6b,c).
Finally, using in silico analyses we tried to verify if miR-16 expression, being correlated with a higher sensi-
tivity to radiation, could have a prognostic value in breast cancer patients. To this aim we used the Kaplan- Meier 
plotter online tool, which allows verifying the prognostic potential of miRNAs in up to four different databases. 
Our analyses showed that both in the Metabric dataset (n = 1262 patients with a median follow up of 94 months) 
and in the TCGA dataset (n = 1061 patients with a median follow up of 25 months) high miR-16 expression pre-
dicts longer overall survival for the patients (Hazard Ratio 0.73 and 0.75 for Metabric and TCGA, respectively) 
(Fig. 6d).
Figure 3. Signal transduction pathways are differently activated by radiation in T47D and MDA-MB-231 
cells. (a) Western blot analysis evaluating the expression of the indicated phospho-proteins in T47D and 
MDA-MB-231 irradiated with 0.5 and 2 Gy doses and the harvested at the indicated time points. Vinculin was 
used as loading control. (b) Western blot analysis evaluating the expression of γH2AX and RAD51 in cells 
irradiated with 2 Gy and then collected at the indicated time points. Full-length blot is shown in Supplementary 
Fig. S1. Vinculin and GAPDH were used as loading control. NIR = Non-Irradiated cells.
DE group Total DEG Upregulated Downregulated
MDA-MB-231 (2 Gy) vs. MDA-
MB-231 (Control) 88 44 44
T47D (2 Gy) vs. T47D (Control) 242 183 59
Table 2. The deregulated miRNAs in the cell exposed to 2 Gy dose at 24 hours. DEG: Differential Expression 
Group.
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Discussion
Radiation resistance represents a relevant clinical unmet need in the treatment of breast cancer patients. 
Identification of molecular markers involved in radiation response could help to identify new drugs as a radio-
sensitizer and could be used as predictive biomarker of radiation response23. Several studies have reported many 
potential targets for enhancement of radiation sensitivity in breast cancer cells24–27.
Here we report the identification of miR-16 as a possible prognostic biomarker in breast cancer starting from 
the analysis of miRNAs modified by radiation in breast cancer cells.
To reach this goal we have characterized an in vitro model of radiation response using two estrogen receptors 
positive and one triple negative breast cancer cell lines. Among the three tested breast cancer cell lines, we selected 
MDA-MB-231 and T47D cells that showed the highest differences in radiation sensitivity. Using clonogenic assay 
to extrapolate radiobiological parameters, we found that T47D had a 3.1 folds higher α value accompanied by a 
1.5 folds higher SF2 when compared to MDA-MB-231 suggesting that they had an intrinsic radiation sensitivity28. 
Similar results were recently reported by Speers et al. that showed a higher survival fraction for MDA-MB-231 
compared to T47D cells at 2 Gy dose29.
Induction of cell cycle arrest in both G1 and G2 cell cycle phases provide time for DNA damages repair fol-
lowing irradiation23. Interestingly, we found a stronger increase of G2/M cell population in T47D compared to 
MDA-MB-231 cells in each dose of radiation. This result is in agreement with the previous findings reporting 
that radiation-induced G2 arrest is more pronounced in radiosensitive respect to radioresistant cells30. These 
Figure 4. Evaluation of miRNAs expression modified by irradiation in breast cancer cells. (a,b) Heat maps of 
the most differentially expressed miRNAs in T47D (a) and MDA-MB-231 (b) cells irradiated with 2 Gy dose 
and analyzed 24 hours after irradiation and compared to the miRNAs expression levels of the respective non-
irradiated cells. (c) Venn diagram of the 5/6 most differentially expressed miRNAs in the two cell lines. In red 
are reported miRNAs overexpressed and in green those downregulated in irradiated cells. FC = Fold change.
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differences are in line with the notion that in response to radiation cancer cells usually activate G2 checkpoint to 
complete DNA repair.
Following irradiation G2 cell cycle arrest is regulated by activation of ATM-CHK2 pathway that eventu-
ally induce the phosphorylation of cyclin- dependent kinase like CDK1 (CDC2) on Tyr-15 by WEE1 kinase, 
preventing CDK1 full activation and inhibiting G2/M transition31. Accordingly, we found in T47D a higher 
radiation-dependent CDK1 phosphorylation that might explain the higher percentage of G2 arrested cells in 
T47D respect to MDA-MB-231.
The tumor suppressor gene TP53 is a validated target of ATM that phosphorylates p53 protein on Ser1532. 
This is an activating phosphorylation that increases p53 transcriptional activity that eventually participates in 
the establishment of the G2 checkpoint following irradiation33. Accordingly, we found that in both T47D and 
MDA-MB-231, p53-Ser15 is phosphorylated although with different kinetics, which might reflect the different 
G2/M arrest observed in the two cell lines. Of note, both T47D and MDA-MB-231 carried a mutated TP53 that 
however could also sustain the radiation-induced G2 arrest34.
EGFR expression and phosphorylation has been associated with decreased efficacy of radiotherapy not 
only in Head and Neck Squamous Carcinoma but also in TNBC cells35,36. In our study, the high expression of 
phosphosho-EGFR was observed in MDA-MB-231, but not in T47D cells supporting the possibility that the 
higher radiation resistance of MDA-MB-231 could be at least partially due to EGFR phosphorylation.
The different activation of signal transduction pathways was also followed by a different expression of γH2AX 
and RAD51, whose persistent expression has been linked to un-rejoined DSB and increased radiosensitivity37.
Interestingly, the different biological and biochemical response of MDA-MB-231 and T47D cells allowed us to 
identify miR-16 as a possible important mediator of response to radiation.
Of course it is possible that other differentially expressed miRNA (e.g. miR-23b-3p) could participate to the 
response to radiation. In the available literature the role of miR-23b-3p in the response to irradiation is still con-
troversial and not investigated in breast cancer38,39, therefore it could be relevant to explore its role in breast cancer 
response to RT in future studies.
The miR-16, which belongs to miR-15/miR-16 cluster, is the example of highly conserved miRNAs able to reg-
ulate several important signaling pathway like cell proliferation, apoptosis and cell cycle40. In the context of breast 
cancer miR-16 has been reported to be down regulated respect to normal breast tissues with the lowest expression 
observed in highly metastatic breast cancer41,42.
Yet, only few other reports have investigated the role of miR-16 in the response to radiation, showing that it 
could promote the sensitivity to radiation of non-small cell lung and breast cancer43,44. Moreover, miR-16 was also 
identified as the regulator of immune response tumor microenvironment after radiation therapy45. In this context 
it is plausible that miR-16 might mediate radiation-induced G2 arrest by the targeting of cell cycle regulators like 
WEE1 and/or CHEK1 that control the G2/M transition and are validated miR-16 target genes. Intriguingly, by 
bioinformatics we also observed that high miR-16 predicts good prognosis in breast cancer patients.
This study has some limitations. First, although our bioinformatics analyses indicated that miR-16-5p may also 
be involved directly in the regulation of genes, those involved in radiation sensitivity include CHEK1, CDC27, 
SMAD3, GADD45G we did not prove in wet lab experiments that these genes are bona fide miR-16 targets in 
control and/or irradiated cells. Similarly, we did not prove that miR-16-5p act as radiosensitizer by modifying its 
expression in radioresistant and in radiosensitive cells and therefore it is possible that the increased expression of 
miR-16 in T47D cells after irradiation is only an epiphenomenon and it does not have a causal role of the increased 
radiosensitivity of these cells. We hope we will be able to better investigate and clarify these points in future studies.
Despite these limitations, our work starting from the analyses of the biological response of different breast 
cancer cell lines to radiation leaded to the identification of miR-16-5p as radiation modified miRNA and as bio-
marker of breast cancer patient’s prognosis, and possible radiosensitivity. Future works on larger cohorts of breast 
cancer patients are necessary to confirm this possibility.
Figure 5. Validation of miR-16-5p expression modification. Graph reporting the normalized expression of 
miR-16-5p in T47D and MDA-MD-231 cells exposed to 2 Gy and collected after 24 hours evaluated by the 
qRT-PCR analysis. The U6 (RNU6-1) snRNA was used as reference gene. Data represent the mean ± standard 
deviation (SD) of two experiments, performed in duplicate. Statistical significance was evaluated using two-way 
analysis of variance (ANOVA), with Tukey’s multiple comparison test. **p < 0.01, ***p < 0.001.
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Methods
Cell culture and radiation exposure. The breast cancer cell lines MDA-MB-231, T47D, and SKBR3 
were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco) and RPMI1640 (Roswell Park Memorial 
Institute medium) (Gibco) containing 100 units/mL of penicillin and 100 mg/mL of streptomycin, supplemented 
with 10% Fetal Bovine Serum (FBS) (Gibco), and maintained in humidified 37 °C incubator with 5% CO2. Cells 
were seeded at different density, and incubated for 24 hours to reach 60–70% confluence for all experiments. Then, 
cells were exposed to different doses of radiation 2, 4, 6, 8, and 10 Gy, using Elekta Compact Linear Accelerator, 
with 6 MeV and dose rate 2 Gy/ min. The medium was changed immediately after irradiation.
Cell viability assay. The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell cyto-
toxicity assay was performed as previously described46. Briefly, cells (8 × 103 cells/well) were cultured in 96-well 
plate, 24 hours before treatment. Cells were irradiated by different doses of radiation (2 to 10 Gy). After incubation 
for 24, 48, 72 and 96 hours, 10 µl MTT (5 μg/ml) was added to each well followed by incubation for 3 hours. Next 
Figure 6. Bioinformatics evaluation of miR-16-5p target genes. (a) The predicted genes target of miR-16-5p 
obtained setting the cut of ≤–0.4 using the target prediction TargetScan V7.2. (b) GO biological process and 
(c) KEGG pathway enrichment analysis evaluating the process/pathways most significantly represented among 
the possible miR-16-5p target genes (as evaluated in a). (d) Kaplan-Meier survival curves evaluating the Overall 
Survival (OS) of stage breast cancer patient included in the METABRIC (n = 1262, left) and TCGA (n = 1061, 
right) datasets, based on the expression of miR-16 using the KM Plotter online tool. HR = Hazard Ratio and 
CI = Confidence Interval. p-values were calculated using the log-rank test.
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100 µl DMSO was added to dissolve precipitation, and kept at room temperature for 10 minutes with gentle shak-
ing. Non-irradiated cells were treated as same procedure. The absorbance was quantified by microplate reader 
(BioTek Instruments, Inc., Winooski, VT, USA) at 540 nm. The viability was normalized to non- irradiated group.
Clonogenic assay. The breast cancer cells were seeded in 6-well plates and let to adhere to the plates. Cells 
were exposed to different doses of radiation (2 to 10 Gy). Then cells were plated in triplicate in 6-well plate and 
maintained at 37 °C and 5% CO2 for 7–14 days. The cells were fixed with 4% (v/v) paraformaldeide, and stained 
with 5% (w/v) crystal violet. Colonies with more than approximately 50 cells were counted manually, and clono-
genic survival fraction (SF) was expressed as the relative plating efficiencies of the irradiated cells to the control 
cells. The linear-quadratic model (LQ model) was used to describe cell survival fraction as the function of radia-
tion dose. The survival fraction was fitted into inverse exponential equation:
SF exp( D D )2= −α − β
In this equation, SF is surviving fraction of cells at dose D, and α and β are two constants of linear and quad-
ratic components of cell killing28.
Cell cycle analysis. Cell cycle distribution was examined by Propidium Iodide (PI) staining according to 
previous protocol47. Briefly, 2 × 105 cells were seeded per well in 6-wells plates, and allowed to attach for 24 hours. 
Plates were then exposed to different doses of radiation and the medium was replaced immediately after irradia-
tion. Irradiated cells were collected 4 and 24 hours after irradiation by tryspinization. Cell suspension was washed 
with ice-cold PBS twice, and fixed by adding 70% (v/v) cold ethanol and under gentle agitation. The cells were 
then maintained in 4 °C in the dark until used. Prior to staining, fixed cell were washed twice in PBS, resuspended 
in PBS supplemented with 100 μg/mL RNase A, 50 μg/mL propidium iodide and 0.1% (v/v) Triton X-100 and 
then incubated at 37 °C for 30 minutes, protected from light. DNA content was quantified by measuring PI flores-
cence signal versus count, using FACSCalibur Flow Cytometer (BD, San Jose, CA, USA). The percentage of cell in 
each phase of the cell cycle was analyzed using the FACSDiva 7.0 software (BD Biosciences).
RNA extraction and sequencing. For RNA extraction, cells in exponential growth phase were subjected 
to irradiation with a 2 Gy dose, replacing medium and incubated for additional 24 hours. The total RNA was 
extracted using TRIzol total RNA isolation reagent (Invitrogen)and Total RNA isolation kit (Norgen Biotek 
Corporation, Canada) according to manufacturer’s instruction. The concentration of RNA was more than 500 ng/
µl for all samples with an OD260/OD280 ratio equal to 2 and more, as quantified by NanoDrop spectrophotom-
eter (NanoDrop Technologies, Wilmington, DE, USA). The RNA integrity was also checked by agarose gel elec-
trophoresis. For small RNA sequencing, total RNA was subjected to ligation 3′ and 5′ small RNA adapters. Then, 
single strand cDNA was synthesized and amplified using specific primers followed by purification and quanti-
fication. The small RNA libraries were loaded on flow cell and then sequenced on Illumina HiSeq2000 genome 
analyzer, using SBS (sequencing by synthesis) method according to manufacturer’s instructions48–50.
miRNA-Seq analysis pipeline. FASTQ files were groomed and subsequently FASTQC algorithm was 
applied to check the presence and the type of adaptor contaminations within FASTQ files. Trimming of FASTQ 
files were then carried out using Trim Galore algorithm51 followed by running FASTQC52 to ensure removing 
of adaptor contaminations. The transcriptome reference sequence was downloaded from miRBase database, 
(Version 22). Mapping of short reads on the reference transcriptome reference sequence were performed apply-
ing HISAT2 algorithm53. Read counts for each feature were calculated using Salmon algorithm54. Finally, DESeq2 
were employed on the resulted read counts to get the list of deregulated miRNAs. Applying the adjusted p-value 
≤0.05 the most significant up and down-regulated genes were selected for downstream studies.
Western blot. To evaluate protein expression, western blot analysis was performed on protein extract of 
cells, were exposed to 0.5 and 2 Gy radiation doses at different time points. For cell lysate preparation, cells were 
washed with cold PBS twice, collected in 100 µl cold RIPA lysis buffer (50 mM Tris HCl pH 8, 1% Igepal, 0.5% 
sodium deoxycholate, 0.1% SDS), containing protease inhibitor cocktail (Complete TM, Roche), 1 mM Na3VO4 
(Sigma), 100 mM NaF (Sigma) and 1 mM DTT (Sigma). Total protein concentration was quantified by stand-
ard Bradford assay (Bio-Rad; CA, USA). 25 to 40 μg of proteins were mixed with 5 µl of Laemmli sample buffer 
and boiled at 95 °C for 5 minutes. The protein samples were then loaded and separated using 4–20% SDS poly-
acrylamide precast gels (Criterion Precast Gel, Bio-Rad). Proteins were transferred to nitrocellulose membranes 
(GE Healthcare), and membrane blocked with 5% Non-Fat Dried Milk (NFDM) in Tris Buffered Saline-Tween 
(TBS) containing 0·1% Tween-20 (TBST) for 1 hour at room temperature (RT). Blocked membranes were incu-
bated overnight at 4 °C using the following primary antibodies: phospho-ATM (Ser1981) (1:1000, #13050), 
phospho-EGFR (Tyr1068) (1:1000, #3777), phospho- p53(Ser15) (1:500, #9284), phospho- cdc2(Tyr 15)(1:1000, 
#9111), Rad51 (D4B10)(1:1000 #8875) were from Cell Signaling Technology, γH2AX(Ser139)(1:1000) and 
GAPDH (6C5 CB1001, 1:1000) were from Millipore, and goat polyclonal antibody against vinculin (1:5000, 
sc-7649 clone N-19) was from Santa Cruz Biotechnology.
After incubation with the primary antibodies membranes were washed in TBST (x3), and incubated with 
secondary antibodies at RT for 1 hour. The Horseradish peroxidase-conjugated goat anti-mouse and goat 
anti-rabbit antibodies (Rockland) were prepared in 5% NFDM in TBST at the concentration of 1:2000. The 
fluorophores-conjugated antibody (AlexaFluor 680, Invitrogen or IRDye 800, Rockland) was diluted 1:1500 in 
Odyssey Blocking Buffer (LI-COR, Biosciences). Finally, proteins expression were detected by Enhanced Chemi 
-Luminescence (ECL) system or Odyssey Imaging scanner (LI-COR), as appropriate. To evaluate the quantity 
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and quality of loaded proteins, we used Vinculin and GAPDH as loading controls. The membranes were stripped 
using the Re-blot Plus Strong Solution 10×(Millipore) diluted 1:10 in ionized water for 10 minutes at room tem-
perature. After washing three times in TBST, the membranes were reblot as described above.
Quantitative real-time PCR (qRT-PCR). Total RNA from 2 Gy irradiated breast cancer cells was extracted 
using TRIzol (Invitrogen) 24 hours after irradiation, then quantified and diluted to reach the concentration 
of 50 nanogram per each µliter. The concentration of RNA was measured by NanoDrop 3300 spectrometer 
(Thermo Scientific, Waltham, MA, US). The cDNA was produced by TaqMan MicroRNA Reverse Transcription 
Kit (Applied Biosystem) as previously described55. Following cDNA dilution, qRT–PCR was carried out using 
TaqMan microRNA assay kit (Applied Biosystems) using the CFX96 Thermocycler (Bio-Rad, USA). U6 (RNU6-
1) snRNA was used to normalize miRNAs expression.
miRNAs target prediction and pathway enrichment analysis. The target prediction of differentially 
expressed miRNA was performed using TargetScan 7.2 bioinformatics software tool (http://www.targetscan.org/
vert_72/)56. The predicted genes were selected by setting the threshold based on the total context score ≤ −0.4. 
Then the genes information were uploaded to Enrichr online database (https://amp.pharm.mssm.edu/Enrichr/) 
to predict target related pathways throughout Gene Ontology (GO) analysis tool and Kyoto Encyclopedia of 
Genes and Genomes (KEGG) pathway57,58. We specifically focused on targets involved in DNA repair, cell cycle 
and apoptosis regulation.
Statistical analysis. Statistical analyses were performed using GraphPad PRISM, Version 8 (GraphPad 
Software Inc. CA) and the difference with p-value below 0.05 was considered significant. The radiobiological 
parameters of cell survival curve were also measured by GraphPad prism.
The LD50 values were estimated using the equation of first order polynomial non-linear regression. Western 
blot images were analyzed using ImageLab analysis software, Version 6 (Bio-Rad, Hercules, CA). Kaplan-Meier 
survival curves were generated using the KM Plotter online tool (http://kmplot.com)59, using the most appropri-
ate cut off choice. KM Plotter is an online algorithm exploitable to interrogate the expression of up to 1052 miR-
NAs on up to 1,262 (METABRIC dataset) or 1061 breast cancer patients (TCGA dataset) with a mean follow-up 
of 94 (METABRIC dataset) or 25 months (TCGA dataset), as described previously60,61.
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